System Transmission

Top Signal

100#1 JOB

Activity

2191Ripe

+949 today

System

Livenow

Terminal Asset View

stockNASDAQ

HRMY

$27.61-0.65%

Harmony Biosciences Holdings Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

12Neutral

Live Analysis Active

Company Mission

Harmony Biosciences creates prescription drugs for people with rare sleep disorders like narcolepsy. These medicines help patients stay awake during the day and manage their symptoms. The company makes money by selling these drugs to patients through pharmacies and healthcare systems.

HRM

Industry Context

The biotech industry focuses on developing treatments for medical conditions. Companies in this space research, test, and sell medicines, often targeting specific diseases where few options exist. Harmony operates in the neurology segment, which deals with brain and nervous system disorders.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

28Matrix

Market Momentum

29.8— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.4x— Normal Volume

Today's Change

-0.65%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing HRMY across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 02:34 PM UTC

As-of 03-15-2026 14:18 UTC

Develops prescription drugs for rare sleep disorders and makes money by selling these medications to patients through pharmacies.

Price dropped too fast and might bounce from oversold levels, suggesting potential short-term recovery.

Biotech sector showing renewed interest in neurological treatments, which could benefit companies focused on sleep disorders.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...